This review highlights preclinical evidence that diabetes accelerates atherosclerosis via altered myeloid cell function, specifically involving S100A9, RAGE, and ACSL1.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Karin Bornfeldt (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: